ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

DCPC Board Ok’s Grant Programs In Prevention, Public Education

October 30, 1992

President Asks $600 Million For NCI In ’75; Research Grants Would Get $19 Million Hike

February 8, 1974

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

October 28, 2011